<<

Chlamydia: A Disease Without a History

Michael Worboys : Most commonly reported STI in UK

Incidence of STIs, 1998-2008

140000

120000 New diagnoses 100000 (primary and 80000 secondary) 60000 (uncomplicated) New casesNew Chlamydia 40000 (uncomplicated) 20000

0 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 Year Venereal Diseases

1860-1930 Venereal Disease/s – syphilis and gonorrhoea

1940s Syphilis, gonorrhoea and ‘Other conditions’

“balanoposthitis, (LGV), non-gonococcal (NGU), thrush, , ulcus actum vulvae, , vulvovaginitis, and warts.” (McLachlan, 1944) Venereal Diseases

Venereologists, 1940s

War – invalidism, tropics,

Special clinics

Bacteriologically- and Laboratory-oriented: Wassermann Reaction Salvarsan, Sulphonamides

Venereal Diseases

1948 WHO Expert Committee on Venereal Diseases First session, 12-16 January 1948

Venereal Diseases

1948 WHO Expert Committee on Venereal Diseases First session, 12-16 January 1948

Venereal Diseases

1948 WHO Expert Committee on Venereal Diseases

1950 A.H. Harkness, Non-gonococcal urethritis: including the genital manifestations of local and systemic diseases and infestations of the urinary tract with , metazoa and fungi.

1951 NGU first recorded, UK men only: 10,764 cases ( Cf. 14,975 gonorrhoea)

1965 NGU cases greater than gonorrhoea. Venereal Diseases

NGU or Non-Specific Urethritis (NSU)

1960s Puzzle Rising incidence – But treatable (sulphonamides and ) Unsatisfactory, residual category Was its cause? inflammatory, or an infection. ? -like agent (TRIC) ? ? Trichomoniasis ? Fungi ? Haemophilus ? Venereal Diseases

NGU - NSU

1970s ‘In spite of much laboratory and other research, non- specific genital infection continues to be the venereologist’s most perplexing problem.’ Robbie Morton, 1975.

‘The Chlamydia genus is in fashion again’. Lancet, 1974

Cell culture of intracellular bacterium Chlamydia ≈ 25-58% of NGU/NSU Chlamydia in the Clinic

1980s NGU/NSU  specific infections Chlamydia, mycoplasma, LGV Role in PID, Culture service

HIV-AIDS STI clinics, specialism Chlamydia co-factor in HIV/AIDS Labs + New biotech companies

GUM, Gynaecology, STIs Chlamydia in the Laboratory

C. trachomatis

Testing Direct ‘Observe’ the organism (culture/microscopy) Proxy Identify antibody Identify antigen

Sensitivity? – Specificity?

‘Gold Standard’ II now

‘Gold Standard’ then

http://www.chlamydiae.com/restricted/docs/labtests/diag_nucleicacidamplification.asp Chlamydia: A Disease without a History

NGU  Chlamydia

NGU Chlamydia NGU > Chlamydia Chlamydia > NGU

New infection or newly recognised?

Increase? – ‘real’? – more you look, more you find?